Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Anna U Loengard is Director at Clover Health Investments, Corp.. OQRO lists 2 transactions filed with the SEC under this name, the latest on Aug 14, 2025, each linked to the official Form 4.
Director
Disclosures on record
2
Companies involved
1
As of the latest filing on , Anna U Loengard reported holding 57,210 shares of Clover Health Investments, Corp. (CLOV), worth about $239K at the last close of $4 (Nov 18, 2026), held through a daughter ira, a son ira.
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Clover Health Investments, Corp. CLOV | 57,210 | 30K daughter ira · 28K son ira | $4 | $239K | Aug 13, 2025 |
Is this Anna U Loengard’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
Clover Health Investments, Corp.CLOV
2 disclosures · Aug 2025 · 2 bought
Aug 13, 2025Bought~$38Kdisclosed Aug 14
DetailsOfficial recordAug 13, 2025Bought~$31Kdisclosed Aug 14
DetailsAnna U Loengard bought shares on the open market in 2023, 2024 and 2025.
Anna U Loengard reported 9 open-market purchases and 0 sales since 2023; purchases in 3 different years, most recently 2025.
| Year | Bought | Sold |
|---|---|---|
| 2025 | $69K2×2 trades | — |
| 2024 | $136K5×5 trades | — |
| 2023 | $14K2×2 trades | — |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
On the latest SEC Form 4, dated Aug 13, 2025, Anna U Loengard reported holding 57,210 shares of Clover Health Investments, Corp. (CLOV), held indirectly. At the last close of $4 on Nov 18, 2026, that is about $239K. This is the stake disclosed in filings, not a net worth.
No public filing gives Anna U Loengard's net worth. What SEC Form 4 shows is the stock stake: 57,210 shares of Clover Health Investments, Corp. (CLOV), about $239K at the last close. Cash, other investments, property, debts and unexercised options are not in these filings, so the real figure can be much higher or lower.
Anna U Loengard bought shares on the open market in 2023, 2024 and 2025.
In SEC filings since 2023: the latest open-market purchase is from 2025; no open-market sale is on record.
Clover Health Investments, Corp. (CLOV), from 2023 to 2025: 9 purchases and 0 sales.
Anna U Loengard reported 9 open-market purchases and 0 sales here, 2023 to 2025.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.